Research Antibodies and Reagents-EMEA Market Status and Trend Report 2013-2023
Report Summary
Research Antibodies and Reagents-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Research Antibodies and Reagents industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Research Antibodies and Reagents 2013-2017, and development forecast 2018-2023
Main market players of Research Antibodies and Reagents in EMEA, with company and product introduction, position in the Research Antibodies and Reagents market
Market status and development trend of Research Antibodies and Reagents by types and applications
Cost and profit status of Research Antibodies and Reagents, and marketing status
Market growth drivers and challenges
The report segments the EMEA Research Antibodies and Reagents market as:
EMEA Research Antibodies and Reagents Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Research Antibodies and Reagents Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Enzyme-linked Immunosorbent Assay
Polymerase Chain Reaction
Western Blotting
Flow Cytometry
Immunofluorescence
Immunoprecipitation
Others
EMEA Research Antibodies and Reagents Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Pharmaceutical & Biotechnological Companies
Academic & Research Institutes
Contract Research Organizations
Others
EMEA Research Antibodies and Reagents Market: Players Segment Analysis (Company and Product introduction, Research Antibodies and Reagents Sales Volume, Revenue, Price and Gross Margin):
Becton Dickinson & Company
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche Ltd.
Merck Millipore
PerkinElmer, Inc.
Lonza Group, AG
QIAGEN N.V.
Abcam
GenScript
Luminex Corporation
Dako
Alere, Inc.
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Research Antibodies and Reagents-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Research Antibodies and Reagents industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Research Antibodies and Reagents 2013-2017, and development forecast 2018-2023
Main market players of Research Antibodies and Reagents in EMEA, with company and product introduction, position in the Research Antibodies and Reagents market
Market status and development trend of Research Antibodies and Reagents by types and applications
Cost and profit status of Research Antibodies and Reagents, and marketing status
Market growth drivers and challenges
The report segments the EMEA Research Antibodies and Reagents market as:
EMEA Research Antibodies and Reagents Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Research Antibodies and Reagents Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Enzyme-linked Immunosorbent Assay
Polymerase Chain Reaction
Western Blotting
Flow Cytometry
Immunofluorescence
Immunoprecipitation
Others
EMEA Research Antibodies and Reagents Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Pharmaceutical & Biotechnological Companies
Academic & Research Institutes
Contract Research Organizations
Others
EMEA Research Antibodies and Reagents Market: Players Segment Analysis (Company and Product introduction, Research Antibodies and Reagents Sales Volume, Revenue, Price and Gross Margin):
Becton Dickinson & Company
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche Ltd.
Merck Millipore
PerkinElmer, Inc.
Lonza Group, AG
QIAGEN N.V.
Abcam
GenScript
Luminex Corporation
Dako
Alere, Inc.
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF RESEARCH ANTIBODIES AND REAGENTS
1.1 Definition of Research Antibodies and Reagents in This Report
1.2 Commercial Types of Research Antibodies and Reagents
1.2.1 Enzyme-linked Immunosorbent Assay
1.2.2 Polymerase Chain Reaction
1.2.3 Western Blotting
1.2.4 Flow Cytometry
1.2.5 Immunofluorescence
1.2.6 Immunoprecipitation
1.2.7 Others
1.3 Downstream Application of Research Antibodies and Reagents
1.3.1 Pharmaceutical & Biotechnological Companies
1.3.2 Academic & Research Institutes
1.3.3 Contract Research Organizations
1.3.4 Others
1.4 Development History of Research Antibodies and Reagents
1.5 Market Status and Trend of Research Antibodies and Reagents 2013-2023
1.5.1 EMEA Research Antibodies and Reagents Market Status and Trend 2013-2023
1.5.2 Regional Research Antibodies and Reagents Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Research Antibodies and Reagents in EMEA 2013-2017
2.2 Consumption Market of Research Antibodies and Reagents in EMEA by Regions
2.2.1 Consumption Volume of Research Antibodies and Reagents in EMEA by Regions
2.2.2 Revenue of Research Antibodies and Reagents in EMEA by Regions
2.3 Market Analysis of Research Antibodies and Reagents in EMEA by Regions
2.3.1 Market Analysis of Research Antibodies and Reagents in Europe 2013-2017
2.3.2 Market Analysis of Research Antibodies and Reagents in Middle East 2013-2017
2.3.3 Market Analysis of Research Antibodies and Reagents in Africa 2013-2017
2.4 Market Development Forecast of Research Antibodies and Reagents in EMEA 2018-2023
2.4.1 Market Development Forecast of Research Antibodies and Reagents in EMEA 2018-2023
2.4.2 Market Development Forecast of Research Antibodies and Reagents by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Research Antibodies and Reagents in EMEA by Types
3.1.2 Revenue of Research Antibodies and Reagents in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Research Antibodies and Reagents in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Research Antibodies and Reagents in EMEA by Downstream Industry
4.2 Demand Volume of Research Antibodies and Reagents by Downstream Industry in Major Countries
4.2.1 Demand Volume of Research Antibodies and Reagents by Downstream Industry in Europe
4.2.2 Demand Volume of Research Antibodies and Reagents by Downstream Industry in Middle East
4.2.3 Demand Volume of Research Antibodies and Reagents by Downstream Industry in Africa
4.3 Market Forecast of Research Antibodies and Reagents in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF RESEARCH ANTIBODIES AND REAGENTS
5.1 EMEA Economy Situation and Trend Overview
5.2 Research Antibodies and Reagents Downstream Industry Situation and Trend Overview
CHAPTER 6 RESEARCH ANTIBODIES AND REAGENTS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Research Antibodies and Reagents in EMEA by Major Players
6.2 Revenue of Research Antibodies and Reagents in EMEA by Major Players
6.3 Basic Information of Research Antibodies and Reagents by Major Players
6.3.1 Headquarters Location and Established Time of Research Antibodies and Reagents Major Players
6.3.2 Employees and Revenue Level of Research Antibodies and Reagents Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 RESEARCH ANTIBODIES AND REAGENTS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Becton Dickinson & Company
7.1.1 Company profile
7.1.2 Representative Research Antibodies and Reagents Product
7.1.3 Research Antibodies and Reagents Sales, Revenue, Price and Gross Margin of Becton Dickinson & Company
7.2 Thermo Fisher Scientific Inc.
7.2.1 Company profile
7.2.2 Representative Research Antibodies and Reagents Product
7.2.3 Research Antibodies and Reagents Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific Inc.
7.3 Bio-Rad Laboratories, Inc.
7.3.1 Company profile
7.3.2 Representative Research Antibodies and Reagents Product
7.3.3 Research Antibodies and Reagents Sales, Revenue, Price and Gross Margin of Bio-Rad Laboratories, Inc.
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 Company profile
7.4.2 Representative Research Antibodies and Reagents Product
7.4.3 Research Antibodies and Reagents Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd.
7.5 Merck Millipore
7.5.1 Company profile
7.5.2 Representative Research Antibodies and Reagents Product
7.5.3 Research Antibodies and Reagents Sales, Revenue, Price and Gross Margin of Merck Millipore
7.6 PerkinElmer, Inc.
7.6.1 Company profile
7.6.2 Representative Research Antibodies and Reagents Product
7.6.3 Research Antibodies and Reagents Sales, Revenue, Price and Gross Margin of PerkinElmer, Inc.
7.7 Lonza Group, AG
7.7.1 Company profile
7.7.2 Representative Research Antibodies and Reagents Product
7.7.3 Research Antibodies and Reagents Sales, Revenue, Price and Gross Margin of Lonza Group, AG
7.8 QIAGEN N.V.
7.8.1 Company profile
7.8.2 Representative Research Antibodies and Reagents Product
7.8.3 Research Antibodies and Reagents Sales, Revenue, Price and Gross Margin of QIAGEN N.V.
7.9 Abcam
7.9.1 Company profile
7.9.2 Representative Research Antibodies and Reagents Product
7.9.3 Research Antibodies and Reagents Sales, Revenue, Price and Gross Margin of Abcam
7.10 GenScript
7.10.1 Company profile
7.10.2 Representative Research Antibodies and Reagents Product
7.10.3 Research Antibodies and Reagents Sales, Revenue, Price and Gross Margin of GenScript
7.11 Luminex Corporation
7.11.1 Company profile
7.11.2 Representative Research Antibodies and Reagents Product
7.11.3 Research Antibodies and Reagents Sales, Revenue, Price and Gross Margin of Luminex Corporation
7.12 Dako
7.12.1 Company profile
7.12.2 Representative Research Antibodies and Reagents Product
7.12.3 Research Antibodies and Reagents Sales, Revenue, Price and Gross Margin of Dako
7.13 Alere, Inc.
7.13.1 Company profile
7.13.2 Representative Research Antibodies and Reagents Product
7.13.3 Research Antibodies and Reagents Sales, Revenue, Price and Gross Margin of Alere, Inc.
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF RESEARCH ANTIBODIES AND REAGENTS
8.1 Industry Chain of Research Antibodies and Reagents
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF RESEARCH ANTIBODIES AND REAGENTS
9.1 Cost Structure Analysis of Research Antibodies and Reagents
9.2 Raw Materials Cost Analysis of Research Antibodies and Reagents
9.3 Labor Cost Analysis of Research Antibodies and Reagents
9.4 Manufacturing Expenses Analysis of Research Antibodies and Reagents
CHAPTER 10 MARKETING STATUS ANALYSIS OF RESEARCH ANTIBODIES AND REAGENTS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Research Antibodies and Reagents in This Report
1.2 Commercial Types of Research Antibodies and Reagents
1.2.1 Enzyme-linked Immunosorbent Assay
1.2.2 Polymerase Chain Reaction
1.2.3 Western Blotting
1.2.4 Flow Cytometry
1.2.5 Immunofluorescence
1.2.6 Immunoprecipitation
1.2.7 Others
1.3 Downstream Application of Research Antibodies and Reagents
1.3.1 Pharmaceutical & Biotechnological Companies
1.3.2 Academic & Research Institutes
1.3.3 Contract Research Organizations
1.3.4 Others
1.4 Development History of Research Antibodies and Reagents
1.5 Market Status and Trend of Research Antibodies and Reagents 2013-2023
1.5.1 EMEA Research Antibodies and Reagents Market Status and Trend 2013-2023
1.5.2 Regional Research Antibodies and Reagents Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Research Antibodies and Reagents in EMEA 2013-2017
2.2 Consumption Market of Research Antibodies and Reagents in EMEA by Regions
2.2.1 Consumption Volume of Research Antibodies and Reagents in EMEA by Regions
2.2.2 Revenue of Research Antibodies and Reagents in EMEA by Regions
2.3 Market Analysis of Research Antibodies and Reagents in EMEA by Regions
2.3.1 Market Analysis of Research Antibodies and Reagents in Europe 2013-2017
2.3.2 Market Analysis of Research Antibodies and Reagents in Middle East 2013-2017
2.3.3 Market Analysis of Research Antibodies and Reagents in Africa 2013-2017
2.4 Market Development Forecast of Research Antibodies and Reagents in EMEA 2018-2023
2.4.1 Market Development Forecast of Research Antibodies and Reagents in EMEA 2018-2023
2.4.2 Market Development Forecast of Research Antibodies and Reagents by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Research Antibodies and Reagents in EMEA by Types
3.1.2 Revenue of Research Antibodies and Reagents in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Research Antibodies and Reagents in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Research Antibodies and Reagents in EMEA by Downstream Industry
4.2 Demand Volume of Research Antibodies and Reagents by Downstream Industry in Major Countries
4.2.1 Demand Volume of Research Antibodies and Reagents by Downstream Industry in Europe
4.2.2 Demand Volume of Research Antibodies and Reagents by Downstream Industry in Middle East
4.2.3 Demand Volume of Research Antibodies and Reagents by Downstream Industry in Africa
4.3 Market Forecast of Research Antibodies and Reagents in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF RESEARCH ANTIBODIES AND REAGENTS
5.1 EMEA Economy Situation and Trend Overview
5.2 Research Antibodies and Reagents Downstream Industry Situation and Trend Overview
CHAPTER 6 RESEARCH ANTIBODIES AND REAGENTS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Research Antibodies and Reagents in EMEA by Major Players
6.2 Revenue of Research Antibodies and Reagents in EMEA by Major Players
6.3 Basic Information of Research Antibodies and Reagents by Major Players
6.3.1 Headquarters Location and Established Time of Research Antibodies and Reagents Major Players
6.3.2 Employees and Revenue Level of Research Antibodies and Reagents Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 RESEARCH ANTIBODIES AND REAGENTS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Becton Dickinson & Company
7.1.1 Company profile
7.1.2 Representative Research Antibodies and Reagents Product
7.1.3 Research Antibodies and Reagents Sales, Revenue, Price and Gross Margin of Becton Dickinson & Company
7.2 Thermo Fisher Scientific Inc.
7.2.1 Company profile
7.2.2 Representative Research Antibodies and Reagents Product
7.2.3 Research Antibodies and Reagents Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific Inc.
7.3 Bio-Rad Laboratories, Inc.
7.3.1 Company profile
7.3.2 Representative Research Antibodies and Reagents Product
7.3.3 Research Antibodies and Reagents Sales, Revenue, Price and Gross Margin of Bio-Rad Laboratories, Inc.
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 Company profile
7.4.2 Representative Research Antibodies and Reagents Product
7.4.3 Research Antibodies and Reagents Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd.
7.5 Merck Millipore
7.5.1 Company profile
7.5.2 Representative Research Antibodies and Reagents Product
7.5.3 Research Antibodies and Reagents Sales, Revenue, Price and Gross Margin of Merck Millipore
7.6 PerkinElmer, Inc.
7.6.1 Company profile
7.6.2 Representative Research Antibodies and Reagents Product
7.6.3 Research Antibodies and Reagents Sales, Revenue, Price and Gross Margin of PerkinElmer, Inc.
7.7 Lonza Group, AG
7.7.1 Company profile
7.7.2 Representative Research Antibodies and Reagents Product
7.7.3 Research Antibodies and Reagents Sales, Revenue, Price and Gross Margin of Lonza Group, AG
7.8 QIAGEN N.V.
7.8.1 Company profile
7.8.2 Representative Research Antibodies and Reagents Product
7.8.3 Research Antibodies and Reagents Sales, Revenue, Price and Gross Margin of QIAGEN N.V.
7.9 Abcam
7.9.1 Company profile
7.9.2 Representative Research Antibodies and Reagents Product
7.9.3 Research Antibodies and Reagents Sales, Revenue, Price and Gross Margin of Abcam
7.10 GenScript
7.10.1 Company profile
7.10.2 Representative Research Antibodies and Reagents Product
7.10.3 Research Antibodies and Reagents Sales, Revenue, Price and Gross Margin of GenScript
7.11 Luminex Corporation
7.11.1 Company profile
7.11.2 Representative Research Antibodies and Reagents Product
7.11.3 Research Antibodies and Reagents Sales, Revenue, Price and Gross Margin of Luminex Corporation
7.12 Dako
7.12.1 Company profile
7.12.2 Representative Research Antibodies and Reagents Product
7.12.3 Research Antibodies and Reagents Sales, Revenue, Price and Gross Margin of Dako
7.13 Alere, Inc.
7.13.1 Company profile
7.13.2 Representative Research Antibodies and Reagents Product
7.13.3 Research Antibodies and Reagents Sales, Revenue, Price and Gross Margin of Alere, Inc.
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF RESEARCH ANTIBODIES AND REAGENTS
8.1 Industry Chain of Research Antibodies and Reagents
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF RESEARCH ANTIBODIES AND REAGENTS
9.1 Cost Structure Analysis of Research Antibodies and Reagents
9.2 Raw Materials Cost Analysis of Research Antibodies and Reagents
9.3 Labor Cost Analysis of Research Antibodies and Reagents
9.4 Manufacturing Expenses Analysis of Research Antibodies and Reagents
CHAPTER 10 MARKETING STATUS ANALYSIS OF RESEARCH ANTIBODIES AND REAGENTS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
